Advanced Non-Clear Cell Renal Cell Carcinoma

Dr McGregor on the Updated NCCN Guidelines for Non–Clear Cell RCCПодробнее

News: A Tailored Approach: Evidence-Based Management Strategies for Advanced/Metastatic ncc-RCCПодробнее

FORTUNE: Tivozanib Plus Nivolumab for Advanced nccRCCПодробнее

Clearing Up Non-Clear Cell Renal Cell Carcinoma ManagementПодробнее

Belzutifan improves PFS, ORR in clear cell renal cell carcinomaПодробнее

August Researcher of the Month - Alexander Chehrazi-Raffle, MD, City of HopeПодробнее

KEYNOTE-B61: first-line lenvatinib + pembrolizumab in non-clear cell RCCПодробнее

Combining lenvatinib & pembrolizumab for non-clear cell RCC: KEYNOTE-B61 study rationaleПодробнее

Biology of Non-clear Cell Renal Cancer Subtypes: KCRS23 Session One | KidneyCANПодробнее

Immunotherapy-based combinations for advanced/metastatic renal cell carcinoma: ASCO GU 2023Подробнее

Advanced Kidney Cancer: What the Urologist Needs to KnowПодробнее

UROwebinar: Management of Metastatic kidney cancerПодробнее

Review of the Data of Frontline Treatment for Non-Clear Cell Kidney CancerПодробнее

Kidney Cancer Highlights from ESMO 2022Подробнее

Adjuvant Therapy for Advanced Kidney Cancer w/ Dr. Rana McKay & Dr. Karim Bensalah | Ep. 56Подробнее

Renal cell carcinomaПодробнее

Kidney Cancer Conference Highlights from ASCO 2022Подробнее

Nivolumab Plus Cabozantinib for Patients With Non-Clear Cell Renal Cell CarcinomaПодробнее

Diagnosis and Management of Localized, Locally Advanced and Advanced Kidney Cancer Webcast (2022)Подробнее